首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 15 毫秒
1.
2.
3.

Background

Single-staged laparoscopic common bile duct exploration (LCBDE) offers clear benefits in terms of cost and shorter hospitalization stays. However, a failed LCBDE requiring conversion to open surgery is associated with increased morbidity. This study reviewed the factors determining success of LCBDE, and created a predictive nomogram to stratify patients for the procedure.

Methods

A retrospective analysis of 109 patients who underwent LCBDE was performed. A nomogram was developed from factors significantly associated with conversion to open surgery and validated.

Results

Sixty-two patients underwent a successful LCBDE, while 47 patients required a conversion to open CBDE. The presence of underlying cholangitis (crude OR 2.70, 95% CI: 1.12–6.56, p = 0.017), together with its subsequent interventions, seemed to adversely increase the rate of conversion to open surgery. The predictive factors included in the nomogram for a failed laparoscopic CBDE included prior antibiotic use (adjusted OR (AOR) 2.98, 95% CI: 1.17–7.57, p = 0.022), previous ERCP (AOR 4.99, 95% CI: 2.02–12.36, p = 0.001) and abnormal biliary anatomy (AOR 9.37, 95% CI: 2.18–40.20, p = 0.003).

Conclusion

LCBDE is useful for the treatment of choledocholithiasis. However, patients who were predicted to have an elevated risk for open conversion might not be ideal candidates for the procedure.  相似文献   

4.
5.

Aims

The aim of this study was to determine whether a combination of the tumour markers carcinoembryonic (CEA) and carbohydrate antigen 19-9 (CA19-9) would be helpful in predicting the prognosis of patients with gallbladder carcinoma (GBC) who underwent resection.

Methods

A retrospective analysis of clinico-pathological features and survival of 390 patients with GBC who were treated between January 2003 and December 2013. Time-dependent receiver operating characteristic (ROC) was used to evaluate the prognostic ability of tumour markers. Combinations of preoperative CEA and CA19-9 were tested as potential prognostic factors.

Results

The evaluation of preoperative CEA and CA19-9 showed that patients with both tumour markers within the normal range had the best prognosis with a median survival of 27 months and R0 rate of 86%. Patients with both tumour markers elevated had the poorest prognosis and lower R0 rate (p < 0.001). The combination of CEA and CA19-9 was an independent risk factor for overall survival. The AUROC at 5 years of combination of CEA and CA19-9 was 0.798, which was similar to CEA (0.765) or CA19-9 (0.771) alone (p = 0.103, p = 0.147).

Conclusions

A combination of an elevated preoperative CEA and CA19-9 was associated with a worse prognosis for patients with GBC who underwent resection.  相似文献   

6.

Background

Pancreatic head adenocarcinoma is commonly diagnosed at an advanced stage when adjacent vascular invasion is present. This study aimed to establish a preoperative prognostic nomogram for patients who underwent attempted curative resectional surgery for pancreatic head cancer with suspected peripancreatic venous invasion.

Methods

Data on all consecutive patients were retrospectively collected from 2012 to 2016 at four academic institutions. The demographic and radiological parameters were analyzed using univariate and multivariate Cox regression analyses. The final nomogram was established using the concordance Harrell's C-indices and calibration curves from data obtained in three institutions and validated in the cohort of patients coming from the fourth institution.

Results

The nomogram was constructed using data from 178 patients while the validation cohort consisted of 61 patients. Age, length of tumor contact, peripancreatic venous abnormalities and lymph node staging were independent factors of overall survival. The nomogram showed good probabilities of survival on calibration curves. The C-index of the model in predicting overall survival (OS) was 0.824 for the validation cohort.

Conclusions

The nomogram accurately predicted OS in patients with pancreatic head cancer with suspected peripancreatic venous invasion after attempted curative pancreatic resectional surgery.  相似文献   

7.
We determined serum apolipoprotein A I and A II concentrations and triglyceride and cholesterol concentrations in serum lipoprotein density classes in 28 male patients with severe ischaemic heart disease (IHD) and with angiographically verified coronary artery disease (CAD) and in age-matched controls. Both triglyceride and cholesterol concentrations in very low density lipoproteins and in low density lipoproteins were higher in IHD-patients than in the controls. The triglyceride but not the cholesterol concentration in serum was higher in IHD-patients than in the controls. The cholesterol in high density lipoproteins and the serum apolipoprotein A I concentration were lower in IHD-patients than in the controls. At least in part the higher triglyceride concentration in very low density lipoproteins could be attributed to a decreased removal of triglycerides from the blood since the fractional removal rate of an i.v. injected artificial triglyceride emulsion (Intralipid) was slower in IHD-patients than in the controls.  相似文献   

8.

Background

Post-hepatectomy Liver Failure (PHLF) remains the primary cause of perioperative death. The kinetics of transaminase levels are usually measured as markers of hepatocellular injury following partial hepatectomy, but their correlation with PHLF and post-operative mortality is unclear. The aim of study was to compare the post-operative transaminase kinetics with short term survival in those patients that developed PHLF.

Methods

A retrospective review of patients with HBV-related HCC and who developed PHLF was performed. Logistic regression analysis was conducted to analyze risk factors for postoperative delayed elevation of ALT (PDE-ALT) PHLF and lethal PHLF.

Result

Of the 69 patients who developed PHLF 36 (52%) died. In those patients who died the mean ± SD ALT and AST rose from day (POD) 1–3 and continued to fluctuate with highly abnormal levels beyond day 3 with a mean ± SD peak ALT level beyond POD 3 of 1851 ± 1644 U/L (p < 0.001).

Conclusions

The kinetics of the post-operative transaminases were significantly correlated with perioperative mortality in those patients who developed PHLF. PDE-ALT indicates an increased risk of death in HBV-related HCC patients with PHLF.  相似文献   

9.

Background

Lymph node metastasis (LNM)has widely been recognized as a poor prognostic indicator for hepatocellular carcinoma (HCC) patients. Preoperative prediction of LNM is important for clinicians to decide on treatment. This study was designed to develop a simple and convenient system to predict LNM.

Methods

Consecutive HCC patients who were suspected to have LNM were divided into a training, an internal validation and an external validation cohort. The receiver operating characteristic (ROC) analysis was used to determine the threshold value of the preoperative serological variables. A nomogram visualization system model was then established.

Result

Of the 287 patients, there were 31 patients who had LNM (10.8%), and 21 of 203 patients (10.3%) were in the training cohort and 10 of 84 patients (11.9%) in the internal validation cohort. Sixteen of 176 patients (9.1%) in the external validation cohort had LNM. The serological indices including neutrophil/lymphocyte rate, age, platelet, prothrombin time, and total protein, were included in the nomogram. The areas of the ROC curve were 0.846, 0.679 and 0.738 in predicting LNM in the training cohort, the internal validation cohort and the external validation cohort, respectively.

Conclusion

The scoring system constructed using the preoperative serological variables predicted LNM in HCC patients.  相似文献   

10.

Background

Hilar malignancy can occasionally be associated with high grade dysplasia (HGD) adjacent to invasive malignancy. For patients with HGD extending into the intrapancreatic bile duct, the authors adopted intrapancreatic bile duct resection (IP-BDR). The aims of this study were to compare the incidence of clinically relevant postoperative pancreatic fistula (CR-POPF), distal R0 resection and local recurrence within the distal bile duct remnant for patients undergoing extrahepatic bile duct resection without pancreaticoduodenectomy (with or without IP-BDR).

Methods

Patients who presented with hilar malignancy and underwent extrahepatic bile duct resection without pancreaticoduodenectomy between January 2005 and December 2016 were identified and the outcomes retrospectively evaluated.

Results

Of 217 patients who met the inclusion criteria 62 (29%) patients underwent IP-BDR. There was a significant difference between patients undergoing standard resection vs. IP-BDR in terms of CR-POPF (5% (8/155) patients: vs 18% (11/62), p < 0.001). There were no significant differences between two groups of R0 status on distal margin (5% (8/155) patients: vs 10% (6/62), p = 0.359). No patient developed recurrence within the residual intrapancreatic bile duct.

Discussion

The incidence of CR-POPF after IP-BDR for hilar malignancies was 18%. IP-BDR was associated with CR-POF, but does not appear to alter survival or local recurrence rate.  相似文献   

11.
We evaluated the improvement in hemodynamic and left ventricular (LV) function in 15 patients with acute myocardial infarction and cardiogenic shock, who were treated with intraaortic balloon counterpulsation (IABP). They were studied by flow-directed right heart catheterization and nuclear angiography. IABP decreased LV end-diastolic volume from 134 to 114 ml and LV end-systolic volume from 100 to 72 ml. LV stroke volume increased from 34 to 42 ml and cardiac output from 3.0 to 3.6 L/min. Global LV ejection fraction increased from 27.6% to 36.1%, and this was due to improvement in regional ejection fraction in ischemic areas. Pulmonary capillary wedge pressure and pulmonary blood volume decreased. Right ventricular ejection fraction also increased significantly. IABP improved LV function in acute myocardial infarction.  相似文献   

12.

Background

Whether clinically significant portal hypertension (CSPH) is a contraindication of partial hepatectomy for patients with hepatocellular carcinoma (HCC) remains controversial. The aim was to assess the impact of CSPH on surgical morbidity, mortality and long-term survival of HCC patients who underwent partial hepatectomy.

Methods

A systematic review and meta-analysis was conducted through analyzing the data published before October 2016 on outcomes following partial hepatectomy for HCC patients with CSPH from the Medline, Embase and CENTRAL databases and related literature.

Results

A total of 16 studies involving 4029 patients met the inclusion criteria. HCC patients with CSPH had increased incidences of severe postoperative complications (pooled odds ratio [OR]: 1.66; 95% CI: 1.31–2.10), surgical mortality (2.56, 1.77–3.70) and 5-year mortality (1.29, 1.11–1.50) compared with patients without CSPH. Subgroup analysis suggested that CSPH had no impact on peri-operative mortality and long-term survival for European HCC patients whose CSPH was diagnosed by the standard surrogate criteria (1.95, 0.96–3.96; 1.24, 0.98–1.55).

Conclusions

CSPH had a negative impact on short- and long-term prognoses for HCC patients undergoing partial hepatectomy. However, CSPH did not affect the prognoses in a subgroup of European HCC patients whose CSPH was diagnosed by the standard surrogate criteria.  相似文献   

13.

Background

Severe pneumonia is associated with high mortality and morbidity, and increased antibiotics resistance in the past decades has further deteriorated its prognosis. In view of the limited range of antibiotics, there is an urgent need to develop new non-antibiotics-based strategies to improve the outcome of severe pneumonia. Furthermore, mortality from severe pneumonia has been largely independent of insulting microbes. Xuebijing, a Chinese medicine extract infusion formula, has been shown to have effects on cytokine reduction, anti-coagulation, and neutralisation of released bacterial cytotoxins. Results of clinical studies show improved outcomes after Xuebijing infusion, including increased survival, reduced hospital admissions, and improved clinical presentations.

Methods

To confirm previous findings, we did a multicenter, double-blinded, randomised trial. Patients who met criteria of severe pneumonia (on the basis of 2007 ATS/IDSA guidelines) were enrolled from 32 tertiary hospitals in China between Dec 1, 2013, and May 30, 2016, after approval from the Institutional Review Board of Zhongshan Hospital. Consent was obtained from all participants. The trial was registered at the Chinese clinical trial registry (ChiCTR-TRC-13003534).

Findings

710 patients were randomly allocated to receive intravenous injections (100 mL) of 0·9% NaCl BID (control) or Xuebijing (in 0·9% NaCl) BID for 5–7 days. Clinical and laboratory parameters were recorded and analysed for efficacy and safety. Xuebijing infusion reduced mortality compared with control solution (25% in the control group vs 16% in the Xuebijing group; p=0·009), and some patients showed an improved pneumonia severity index (46% in the control group vs 61% in the treatment group; p<0·0001). Similar results were obtained for sequential organ failure assessment, lung injury score, multiple organ dysfunction score, and systemic inflammatory response syndrome after Xuebijing infusion. Chest X-ray image analysis showed a greater resolution of infiltration in the treatment group than in the control group.

Interpretation

Taken together, Xuebijing infusion combined with standardised treatment could reduce mortality in patients with severe pneumonia, suggesting that Xuebijing could be a potential and promising adjunct therapy in severe pneumonia.

Funding

This study was supported by Tianjin Science and Technology committee grant (14ZXLJSY00230) and Tianjin Chase Sun Pharmaceutical.  相似文献   

14.
The effects of acute myocardial infarction on the pharmacokinetics of digoxin were studied. Digoxin, 0.75 mg, was given orally to 12 patients with left-sided cardiac failure due to acute myocardial infarction and to 9 healthy control subjects. Serum concentration of digoxin in the first 4 hours and the area under the serum concentration-time curve in the first 12 hours after administration of the drug were lower in patients with infarction than in control subjects (P less than 0.01). The 24 hour area under the concentration curve, the amount excreted in urine and the renal clearance did not differ between the groups. The 24 hour area under the concentration curve correlated with the predigoxin pulmonary capillary wedge pressure and with heart rate (P less than 0.01). The decrease of renal clearance of digoxin was related to the serum activity of MB isoenzyme of creatine kinase (P less than 0.001). Morphine reduced and delayed the peak serum concentrations of digoxin (P less than 0.001). Thus, the absorption of oral digoxin was slower and the peak concentrations remained lower in patients with acute myocardial infarction than in healthy control subjects. However, the total amount of digoxin absorbed was unchanged.  相似文献   

15.
16.
This is a report of successful dilation of stenosis of the common trunk in a case of total anomalous pulmonary vein return into the left superior vena cava in a 3 month old infant. Percutaneous angioplasty was performed with a 6 mm diameter balloon catheter. Right ventricular systolic pressure decreased from 96 to 60 mm Hg, mean pulmonary vein pressure decreased from 26 to 14 mm Hg and left ventricular systolic pressure increased from 70 to 90 mm Hg.  相似文献   

17.

Background

The question of which antidepressants should be preferred for the treatment of post-stroke depression is controversial, and pairwise meta-analyses cannot provide a hierarchy of these interventions. We aimed to integrate the available evidence to create hierarchies of the comparative efficacy and acceptability of treatments.

Methods

We did a multiple-treatments meta-analysis (which uses both direct and indirect comparisons) of randomised controlled trials to compare antidepressants and placebo in the acute treatment of post-stroke depression. Electronic databases (MEDLINE, Embase, PsycINFO, Cochrane Central Register of Controlled Trials [CENTRAL], Web of Science) were searched up to Dec 31, 2016. We included only randomised controlled trials that compared antidepressants as monotherapy in patients with post-stroke depression. The patients had to have had a stroke diagnosed clinically or by CT scan or MRI and have been subsequently diagnosed with depression. We applied no inclusion restrictions on the basis of patient and study characteristics, such as age, sex, study dates, and class of antidepressants. The primary outcome was overall efficacy, defined as the mean change of the total depression score between baseline and 6 weeks. If 6-week data were not available, we used data from between 4 and 12 weeks (the datapoint closest to 6 weeks was given preference). The secondary outcome was acceptability, defined as risk of all-cause discontinuation. We tested for inconsistency with the design-by-treatment interaction model that provides a single inference, using the χ2 test. This study has been registered with PROSPERO, number CRD42017054741.

Findings

We identified 12 suitable trials, with data from 707 participants. 11 antidepressants were assessed in the trials, including placebo. All drugs were significantly more effective than placebo apart from sertraline (odds ratio [OR] ?0·61, 95% CI ?1·47 to 0·25), nefiracetam (OR 0·51, ?0·17 to 1·19), and fluoxetine (OR 0·46, ?0·35 to 1·27). For efficacy, standardised mean differences, compared with placebo, varied from ?6·54 (95% CI ?8·42 to ?4·65) for the best drug (reboxetine) to 0·51 (?0·17 to 1·19) for the worst drug (nefiracetam). Reboxetine, paroxetine, and doxepin were the most efficacious treatments (ranked in order), the cumulative probabilities of which were 100%, 85·7%, and 83·2%, respectively. For acceptability, ORs compared with placebo ranged from 0·09 (95% CI 0·00 to 1·83) for paroxetine to 3·42 (0·73 to 15·91) for citalopram. Patients assigned to paroxetine had significantly lower all-cause discontinuation than those assigned to doxepin (OR 0·04, 95% CI 0·00 to 0·73), citalopram (OR 0·03, 0·00 to 0·78), and fluoxetine (OR 0·04, 0·00 to 0·89); all other comparisons were not significant. Paroxetine (cumulative probability 92·4%), placebo (63·5%), and sertraline (57·3%) were the most acceptable treatments. Comparison-adjusted funnel plots for efficacy and acceptability were largely symmetrical. For acceptability (all-cause discontinuation), we found no evidence of inconsistency (p=0·91). For efficacy, we detected some inconsistency (p=0·0230).

Interpretation

After weighing up the efficacy and acceptability, we conclude that paroxetine might be the best choice in the acute treatment of post-stroke depression, and fluoxetine might be the worst choice. More large-scale and high-quality studies are needed to support these findings.

Funding

The Program of Liaoning Province Education Administration (number LK201605) to YS, and the Shenyang Population and Health Technical Critical Special Project (number F16-206-9-01) and Program of the Distinguished Professor of Liaoning Province, Neurology, to CZ.  相似文献   

18.

Background

To investigate the clinical value of the alpha-fetoprotein (AFP) response following transcatheter arterial chemoembolization (TACE) in intermediate-stage hepatocellular carcinoma (HCC).

Methods

Data on patients with Barcelona Clinic Liver Cancer B staging system were analyzed. An AFP response was defined as a decrease in AFP of more than 20% after a TACE session. The association between AFP response and treatment outcome regarding imaging response and overall survival (OS) was explored. Cox proportional hazards models were applied to identify independent risk factors for OS after TACE.

Results

Of the enrolled 376 patients with elevated serum AFP >20 ng/mL, 214 (57%) with AFP responses were identified. AFP responders had improved median survival than non-responders (20 vs. 12 months, P = 0.002). AFP response was significantly correlated with imaging response (P < 0.001). The Cox proportional hazards model revealed that AFP response was an independent factor for OS (hazard ratio, 0.59; 95% confidence interval, 0.45–0.78; P < 0.001). In stratified analyses, an AFP response achieved improved survival in patients with tumor diameters ≤5 cm, diameters >5 cm, tumor number ≤3 and without underlying cirrhosis.

Conclusions

The AFP response indicates enhanced survival after TACE in patients with intermediate-stage BCLC.  相似文献   

19.
Serum creatine kinase was assessed in 94 consecutive patients without convulsions admitted to hospital due to suspicion of infection of the central nervous system. No reliable discrimination between patients with aseptic and those with bacterial meningitis was obtained. Patients with bacterial meningitis and brain oedema, as well as patients with encephalitis, had significantly higher values (P less than 0.01) than patients with meningism, aseptic meningitis and bacterial meningitis without cerebral oedema. Very high values, above 2500 U/1, were encountered in only the most severe cases of bacterial meningitis. The highest serum CK value found in patients with encephalitis was 725 U/l. Reference values for control patients with meningism were 16-269 U/1. In a subset of 9 patients creatine kinase isoenzyme analysis was performed. In all cases only muscle type (MM) isoenzyme was found.  相似文献   

20.
Although surgical removal is the therapy of choice in patients with pheochromocytoma, medical management is necessary in the preoperative preparation of these patients and in inoperable cases. An α-adrenoceptor-blocking agent is routinely used as initial therapy to control hypertension, with a β-blocker used as a second-step agent to control tachycardia when indicated. Doxazosin, a selective α1-inhibitor used as an antihypertensive agent for the reduction of coronary heart disease risk in hypertensive patients, appears to be a good agent to control blood pressure with minimal changes in heart rate. The aim of this study was to assess the antihypertensive efficacy and safety of doxazosin when used alone or in conjunction with a β-blocker in 24 patients with pheochromocytoma. Overall excellent or good antihypertensive efficacy was assessed by physicians in 19 of 24 patients (79.2%) enrolled in the study. Doxazosin monotherapy was effective in eight of 12 patients (66.7%), and combined therapy with a β-blocker was effective in 11 of 12 patients (91.7%). The mean pulse rate remained constant throughout therapy. Adverse reactions were minor and transient and occurred in only three patients. Urinary and plasma catecholamine levels tended to decrease or remained unchanged during doxazosin therapy. There were no clinically hazardous abnormalities or problems in hematologic and biochemical laboratory data. Overall, doxazosin was considered very useful or useful in 83.3% of patients. In conclusion, doxazosin appears to be an excellent agent for the management of hypertension assoclated with pheochromocytoma.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号